Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Research: GLP-1 Medication Users Reduce Spending on Groceries and Dining Out - Featured image
Health

Research: GLP-1 Medication Users Reduce Spending on Groceries and Dining Out

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·December 26, 2025·2 min read

On this page

  • GLP-1 Users Reduce Spending on Groceries and Dining Out
  • Decreased Grocery Spending
  • Shifting Spending Habits

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

A recent study published in the Journal of Marketing Research indicates that families using GLP-1 medications are reducing their spending on food. The research examined purchasing habits and revealed a correlation between GLP-1 use and decreased spending on groceries and dining out.

Share

On this page

  • GLP-1 Users Reduce Spending on Groceries and Dining Out
  • Decreased Grocery Spending
  • Shifting Spending Habits

GLP-1 Users Reduce Spending on Groceries and Dining Out

According to a study featured in the Journal of Marketing Research on December 18, families using GLP-1 medications are allocating less money to food, encompassing both grocery stores and restaurants.

GLP-1 drugs, such as Ozempic, Wegovy, and Mounjaro, function by regulating blood sugar levels, suppressing appetite, and facilitating weight loss. It's estimated that 1 in 8 adults currently use a GLP-1 medication.

The study, which analyzed data from 150,000 households, demonstrated a clear connection between the use of GLP-1 medications and changes in a family's purchasing behavior.

Decreased Grocery Spending

Within six months of a family member starting a GLP-1 medication, grocery store expenditures decreased by 5.3%. Notably, higher-income households experienced an even more significant reduction of 8.2%. Health tracking apps like Shotlee can help monitor dietary changes during this period.

Purchasing preferences also shifted, with a 10.1% decline in snack purchases, along with similar decreases for sweets, baked goods, and cookies. Sales of bread, meat, and eggs also experienced a decline.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Conversely, spending on yogurt, fresh fruit, nutrition bars, and meat snacks saw an increase.

Shifting Spending Habits

According to assistant professor Sylvia Hristakeva, a co-author of the study, the primary trend is a decrease in overall food purchases. She further noted that spending habits become ingrained once consumers establish them. Even when some users discontinue GLP-1 use, these spending patterns persist, making them harder to differentiate from pre-adoption spending habits.

The research extended beyond grocery shopping, revealing that spending at fast-food establishments, coffee shops, and other limited-service eateries decreased by approximately 8%.

However, about one-third of the participants discontinued GLP-1 use during the study and reverted to their prior habits. According to the study's authors, "Their grocery baskets became slightly less healthy than before they started, driven in part by increased spending on categories such as candy and chocolate."

Source Information

Originally published by PEOPLE.com.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: Weight Loss

All Weight Loss articles →
New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It
Wellness & Health

New Yorkers Are Ordering Peptides Like Takeout – And California Trim Clinic Is Behind It

New York City is experiencing a surge in peptide therapy requests via telehealth platforms. This article explores the most popular compounds, safety protocols, and how to track results effectively.

8 min read

More in Health

Ozempic 2.0? Exploring the Future of Weight Loss Medications
Health

Ozempic 2.0? Exploring the Future of Weight Loss Medications

New weight loss drugs, potentially available in oral form, are under development by Eli Lilly and Novo Nordisk. These medications aim to manage type-2 diabetes and facilitate weight loss, potentially offering a more accessible and convenient alternative to current injectables.

4 min read
Wegovy Weight Loss Pill: Potential Availability in Canada - What to Know
Health

Wegovy Weight Loss Pill: Potential Availability in Canada - What to Know

The Wegovy pill, the first oral medication for weight loss in adults, might be available in Canada if approved by health officials. The medication has already been approved in the U.S. and has shown promising results in clinical trials.

3 min read
Are Replicas of Ozempic and Wegovy Safe? Understanding Compounded GLP-1s
Health

Are Replicas of Ozempic and Wegovy Safe? Understanding Compounded GLP-1s

Compounded semaglutide medications are custom-made by compounding pharmacies, containing the active ingredient in Ozempic and Wegovy. However, they are not FDA-approved and carry potential risks. This article explains what you need to know about these alternatives.

12 min read
Share this article
  1. Home
  2. Blog
  3. Research: GLP-1 Medication Users Reduce Spending on Groceries and Dining Out
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community